Drug
Pegfilgrastim-cbqv
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Device Malfunction | 822 | 195.4 | 510.6 | signal |
| 2 | No Adverse Event | 636 | 56.8 | 108.0 | signal |
| 3 | Device Failure | 31 | 32.3 | 33.1 | signal |
| 4 | Syringe Issue | 13 | 11.7 | 11.8 | signal |
| 5 | Neutrophil Count Decreased | 28 | 10.9 | 11.1 | signal |
| 6 | Device Leakage | 24 | 8.9 | 9.1 | signal |
| 7 | Product Dose Omission Issue | 150 | 8.3 | 9.2 | signal |
| 8 | Needle Issue | 14 | 7.7 | 7.8 | signal |
| 9 | Device Adhesion Issue | 7 | 7.3 | 7.3 | signal |
| 10 | Injury Associated With Device | 8 | 6.3 | 6.3 | signal |
| 11 | Accidental Exposure To Product | 39 | 6.2 | 6.3 | signal |
| 12 | Incorrect Dose Administered By Device | 9 | 5.6 | 5.6 | signal |
| 13 | Device Use Error | 9 | 4.2 | 4.2 | signal |
| 14 | Device Use Issue | 4 | 3.6 | 3.7 | signal |
| 15 | Exposure Via Skin Contact | 5 | 3.5 | 3.5 | signal |
| 16 | Device Delivery System Issue | 5 | 3.0 | 3.0 | signal |
| 17 | Device Issue | 16 | 2.9 | 2.9 | signal |
| 18 | Application Site Pain | 4 | 2.9 | 2.9 | no signal |
| 19 | Wrong Technique In Device Usage Process | 8 | 2.8 | 2.8 | signal |
| 20 | Device Dislocation | 7 | 2.5 | 2.6 | signal |
| 21 | Application Site Erythema | 3 | 1.8 | 1.8 | no signal |